POSTER SESSION III Tuesday, March 1, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B BREAST PATHOLOGY 24 Interlaboratory Comparison of ER Testing by Immunohistochemistry Using Tissue Microarrays (231) RR Tubbs, ED Hsi, AR Cohen, DD Dorfman, PL Fitzgibbons, MD Linden, RR Rickert, MM Bui, PC Roche, DD Murphy - College of American Pathologists, Northfield, IL 25 Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma: A Tissue Microarray Based Study (204) A Radhakrishnan, A Nassar, IA Cabrero, G Cotsonis, L Lyons, C Cohen - Emory University School of Medicine, Atlanta, GA; Mexican Oncology Hospital, Col Roma, Mexico; Emory University School of Public Health, Atlanta, GA 26 A New Anti-ER Rabbit Monoclonal Antibody Improves Efficiency of Immunohistochemical Evaluation of ER Status in Breast Cancer (145) AM Gown, TS Barry, P Kandalaft, LC Goldstein, CC Tse, DO Treaba - PhenoPath Laboratories and IMPRIS, Seattle, WA 27 Expression of PHD (prolyl hydroxylase)-1, PHD-2 and PHD3 Is Upregulated in the Nucleus and Cytoplasm in Neoplastic Breast Disease and Nuclear PHD Expression Is Associated with the Estrogen Receptor in Invasive Breast Carcinomas (140) SB Fox, H Turley, L Campo, C Han, KC Gatter, AL Harris - University of Oxford, Oxford, Oxon, United Kingdom 28 Cyclin D1 Overexpression Is Associated with Estrogen Receptor Expression in Caucasian but Not African-American Cases of Breast Cancer (187) L Memeo, AK Joe, H Li, A Troxel, H Hibshoosh - Columbia University Medical Center, New York, NY 29 Estrogen Receptor beta Expression in Myoepithelial and Stromal Cells in Benign and Malignant Breast Tissues (120) YJ Choi Yale School of Medicine, New Haven, CT 30 Molecular Clonality Assay Determination of Ipsilateral Breast Failure Invasive Carcinomas in Patients Treated with Breast Conserving Therapy: Comparison with Clinical and Biologic Factors (144) NS Goldstein, FA Vicini, S Hunter, E Odish, LJ Kestin - William Beaumont Hospital, Royal Oak, MI 31 Molecular Clonality Relationships of Distant Metastases Following Ipsilateral Breast Failure (IBFs) in Patients Treated with Breast Conserving Therapy: Some Distant Metastases Derive from IBFs and Evidence That Metastases Metastasize (103) N Baniseed, NS Goldstein, S Hunter, FA Vicini, LJ Kestin - William Beaumont Hospital, Royal Oak, MI 32 Morphologic Features of Ipsilateral Recurrent Breast Cancers in Patients Treated with Breast Conserving Therapy (BCT) (153) L Huo, Y Wu, F Meric, AA Sahin M. D. Anderson Cancer Center, Houston, TX 33 Clinicopathological Relevance of Akt, Bad, Caspase-3, and Ki-67 in Breast Carcinoma Following Neoadjuvant Chemotherapy (198) G Peiro, E Adrover, FI Aranda, C Alenda, MF Peiro, A Paya, J Segui - Hospital General Universitari, Alacant, Spain 34 Histologic and Biomarker Assessment of Residual Breast Carcinoma in Surgical Specimens after Neoadjuvant Chemotherapy (234) RW Vancura, F Fan, C Connor, A Namiq, PA Thomas, OW Tawfik - University of Kansas Medical Center, Kansas City, KS 35 Locally Advanced Breast Cancer. A Study of Predictive Factors of Pathological Response to Treatment with Primary Chemotherapy (98) FJ Andreu, A Sáez, M Sentís, JC Martín, M Rey - UDIAT-Centre Diagnbstic - Corporació Parc Taulí, Sabadell, Barcelona, Spain 36 Aberrant Promoter Methylation Profiling of Breast Cancer Using Quantitative Methylation-Specific PCR (19) PM Monteiro, C Jerónimo, R Henrique, AL Carvalho, MO Hoque, I Pais, C Leal, C Lopes, MR Teixeira, D Sidransky - Portuguese Oncology Institute, Porto, Portugal; Johns Hopkins University School of Medicine, Baltimore, MD; Portuguese Oncology Institute, Porto, Portugal 37 Prognostic Significance of Combined Use of Histologic Grade and Ki-67 in Breast Cancer (97) C Alenda, FI Aranda, R Durán, FM Peiró, G Peiró, J Seguí, E Adrover - Hospital General Universitario de Alicante, Spain 38 The Value of Digital Microscopy in Enhancing Accuracy and Reliability in Grading Breast Carcinomas. The Newly Proposed KU Grading System and Its Correlation with Patients' Survival (229) O Tawfik, M Davis, S-M Lai, F Fan, J Donahue, P Thomas - Kansas University Medical Center, Kansas City, KS 39 BRAF and ERK2 Kinases in Invasive Breast Carcinoma: Absence of BRAF Mutation and Correlation of ERK2 Subcellular Distribution with Clinical Outcome (194) L Nakopoulou, E Mylona, P Rafailides, P Alexandrou, A Seata, Ch Apostolopoulos, S Markaki, A Keramopoulos - Medical School, National and Kapodistrian University of Athens, Athens, Greece; Alexandra Hospital, Athens, Greece 40 Heat Shock Protein Expression in Invasive Ductal Carcinoma of the Breast (213) TC Rubinas, S Alkan, PB Rajan - Loyola University Medical Center, Maywood, IL 41 Expression of p27 in Primary Versus Metastatic Breast Carcinomas: Its Prognostic Significance and Relation to Other Prognostic Markers (195) AL Namiq, OW Tawfik, F Fan, PA Thomas University of Kansas, Kansas City, KS 42 Skp2 and p27 Cell Cycle Marker Expression in 155 Invasive, Poorly Differentiated Duct Carcinomas with Clinicopathologic Correlation (193) MP Murray, CL Aubertine, E Hyjek, SJ Shin - Weill Medical College Cornell University, New York, NY 43 15-LOX and COX-2 Expression in Breast Cancer: Correlation with Estrogen Receptor and Prognosis (196) A Nassar, A Radhakrishnan, IA Cabrero, GA Cotsonis, C Cohen - Emory University School of Medicine, Atlanta, GA; Mexican Oncology Hospital, Mexico; Emory University School of Public Health, Atlanta, GA 44 Syndecan-1 and Syndecan-4 Expression in Breast Carcinoma Corrrelates with High Proliferative Rate and Absence of Estrogen Receptors (225) K Swartz, R Van Buren, F Baba, Y Zhang, W Wolberg, J Eickhoff, A Friedl - University of Wisconsin, Madison, WI 45 Claudin-7 Has Different Expression Pattern in the Breast Cancers Compared to the Colorectal Cancers (99) YK Bae, JH Choi, MJ Kim Yeungnam University Medical Center, Daegu, Korea 46 Expression of Focal Adhesion Protein Paxillin Is a Good Prognostic Indicator in Breast Carcinoma (178) R Madan, R Cocker, K Oktay, M Oktay - Montefiore Med Ctr, Bronx, NY 47 Loss of 14-3-3 Sigma Expression Associates with Favorable Prognosis in Breast Carcinoma (245) B Yang, AA Roma, BJ Yoder, S Tarr, E Tso, T Choueiri, T Budd, JP Crowe, DG Hicks - Cleveland Clinic Foundation, Cleveland, OH 48 Potential Roles of T-Lymphocytes and Nature Killer Cells in Human Mammary Myoepithelial Cell Layer Disruptions and Tumor Invasion (179) YG Man, T Vinh, C Zhao, A Walker, R Barner Armed Forces Institute of Pathology, Washington, DC 49 Cytoplasmic Expression of SHPS-1 Correlates with Malignant Progression in Breast Carcinomas (244) T Yamamoto, K Oda, Y Nimura, M Hamaguchi - Aichi Prefectural Owari Hospital, Ichinomiya, Aichi, Japan; Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan 50 BTG2 Expression in Human Breast Cancer (111) EF Brachtel, H Kawakubo, S Maheswaran - Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA 51 Reduction of Tumor Suppressors and Elevation of Cytotoxic Cells in Myoepithelial Cell Layers of Inflammatory Breast Carcinoma: Implication for Tumor Aggressiveness (238) LP Wang, C Mannion, YG Man - General Hospital of Military in Beijing, Beiijing, China; Hackensack Medical Center, Hackensack, NJ; Armed Forces Institute of Pathology, Washington, DC 52 Notch1 Expression in Benign and Malignant Mammary Epithelium (125) GM Crisi, SS Schneider - Baystate Medical Center/Tufts University School of Medicine, Springfield, MA; Baystate Medical Center/University of Massachusetts, Springfield, MA 53 Expression and Initial Characterization of the Tetraspanin Superfamily Member NET6, a New Candidate Tumor Suppressor Gene, in Breast Cancer Cells In Vitro and In Vivo (152) H Huang, J Groth, D Fleming, K Sossey-Alaoui, R Sawhney, L Hawthorn, J Geradts - Roswell Park Cancer Institute, Buffalo, NY 54 Microsomal Prostaglandin E2Synthase-1 in Breast Cancer: A Possible Target for Chemoprevention (192) A Morimiya, S Mehrotra, B Agarwal, R Konger, S Badve - Indian Univ-Purdue Univ, Indianapolis, IN 55 Microsomal Prostaglandin E2 Synthase-1 in Breast Cancer Progression (186) SP Mehrotra, A Morimiya, B Agarwal, R Konger, S Badve Indiana University, Indianapolis, IN 56 Detection of Human Papilloma Virus (HPV) Sequences in Breast Cancer Samples of Mexican Patients (199) MD Perez-Montiel, DF Cantu de Leon, I Mikyskova, TA Vela, JG Chanona Vilchis, R Pichardo, HR Dominguez-Malagon, O Hes - Instituto Nacional de Cancerologia, Mexico City, Mexico; University of Pilzen, Pilzen, Czech Republic; Hospital Medica Sur, Mexico City, Mexico 57 Electronic Reporting of Breast Surgical Pathology (127) NM Diaz, CE Cox, V Vrcel, S Clark, J King, K Dawson - Moffitt Cancer Center and Research Institute, Tampa, FL